Skip to main content
Cardiosense Recieves FDA De Novo Classification for Novel Cardiac Technology Designed to Improve Care for Patients with Heart Failure Read the press release

Media Coverage

FDA gives greenlight to new AI tool for managing heart failure patients

FDA gives greenlight to new AI tool for managing heart failure patients

Keep reading